for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Danaher Corporation

DHR.N

Latest Trade

146.47USD

Change

0.72(+0.49%)

Volume

2,699,088

Today's Range

145.83

 - 

147.32

52 Week Range

94.62

 - 

147.32

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
145.75
Open
146.31
Volume
2,699,088
3M AVG Volume
47.04
Today's High
147.32
Today's Low
145.83
52 Week High
147.32
52 Week Low
94.62
Shares Out (MIL)
717.37
Market Cap (MIL)
104,556.30
Forward P/E
30.53
Dividend (Yield %)
0.47

Next Event

Dividend For DHR.N - 0.1700 USD

Latest Developments

More

Envista Holdings Corp Shares Open 16.6% Above IPO Price In Debut

Envista Announces Pricing Of Initial Public Offering

Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Industry

Scientific & Technical Instr.

Contact Info

2200 Pennsylvania Ave NW Ste 800w

+1.202.8280850

http://www.danaher.com/

Executive Leadership

Steven M. Rales

Chairman of the Board

Matthew R. McGrew

Chief Financial Officer, Executive Vice President

Rainer M. Blair

Executive Vice President

Daniel L. Comas

Executive Vice President

William K. Daniel

Executive Vice President

Key Stats

1.67 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

16.9K

2017

18.3K

2018

19.9K

2019(E)

20.7K
EPS (USD)

2016

3.610

2017

4.030

2018

4.520

2019(E)

4.798
Price To Earnings (TTM)
42.79
Price To Sales (TTM)
5.16
Price To Book (MRQ)
3.42
Price To Cash Flow (TTM)
27.88
Total Debt To Equity (MRQ)
31.98
LT Debt To Equity (MRQ)
31.50
Return on Investment (TTM)
5.38
Return on Equity (TTM)
4.87

Latest News

GE inks $21 billion biopharma sale to Danaher in U-turn under Culp

General Electric said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion in the biggest strategy reversal since Lawrence Culp took over as the industrial conglomerate's chief executive in September.

GE debt rallies, bond insurance price drops on Danaher deal

General Electric Co bonds rallied broadly on Monday after the company struck a deal to sell its biopharma business to Danaher Corp for $21.4 billion and said it would use cash from the deal to ease its massive debt burden.

GRAPHIC-GE debt rallies, bond insurance price drops on Danaher deal

General Electric Co bonds rallied broadly on Monday after the company struck a deal to sell its biopharma business to Danaher Corp for $21.4 billion and said it would use cash from the deal to ease its massive debt burden.

Danaher to IPO dental unit after $21.4 bln deal to buy GE's biopharma business

Medical equipment maker Danaher Corp said it was considering an initial public offering for its dental business, citing the size of its $21.4 billion purchase of General Electric Co's biopharma business.

GE sells biopharma drug business to Danaher for $21.4 bln

General Electric Co said on Monday it would sell its biopharma business to Danaher Corp for $21.4 billion, as the U.S. industrial conglomerate sheds non-core businesses to focus on its industrial unit.

Danaher sees one cent per quarter impact from U.S.-China tariffs

Danaher Corp said on Thursday it expects an earnings impact of a cent per quarter from the U.S.-China trade tariff dispute.

Danaher sees one cent per quarter impact from U.S.-China tariffs

Danaher Corp said on Thursday it expects an earnings impact of a cent per quarter from the U.S.-China trade tariff dispute.

Danaher's dental spinoff plan, profit beat push shares higher

Danaher Corp <DHR.N> said on Thursday it would spin off its dental unit into a publicly traded company, as the medical equipment maker seeks to revitalize a struggling business.

Danaher Corp to spin-off dental business

Medical device maker Danaher Corp said on Thursday that it plans to spin-off its dental business, which had annual sales of nearly $3 billion in 2017, into a publicly traded company.

BRIEF-Danaher approached GE about deal for GE’S life-sciences unit - WSJ

* DANAHER APPROACHED GE ABOUT DEAL FOR GE'S LIFE-SCIENCES UNIT - WSJ, CITING SOURCES Source text: https://on.wsj.com/2vOJ3lk Further company coverage:

BRIEF-Danaher Reports Q1 Adjusted Non-Gaap Earnings Per Share $0.99

* SEES Q2 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $1.07 TO $1.10

BRIEF-Danaher Corp Says CEO Thomas Joyce's FY 2017 Total Compensation Was $14.8 Mln

* DANAHER CORP SAYS PRESIDENT AND CEO THOMAS JOYCE, JR'S FY 2017 TOTAL COMPENSATION WAS $14.8 MILLION VERSUS ABOUT $13 MILLION IN FY 2016 - SEC FILING

BRIEF-Danaher Says Entered Into $1 Bln 364-Day Revolving Credit Facility​

* DANAHER CORP SAYS ON MARCH 23, 2018, CO ENTERED INTO A $1.0 BILLION 364-DAY REVOLVING CREDIT FACILITY - SEC FILING

BRIEF-Danaher To Acquire Integrated DNA Technologies

* DANAHER TO ACQUIRE INTEGRATED DNA TECHNOLOGIES Source text for Eikon: Further company coverage:

BRIEF-Danaher Reports Q4 EPS Of $1.21

* SEES Q1 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.90 TO $0.93

BRIEF-Danaher Sees FY 2018 Adjusted Earnings Per Share $4.25 To $4.35

* SEES FY 2018 ADJUSTED NON-GAAP EARNINGS PER SHARE $4.25 TO $4.35

BRIEF-Danaher Announces Leadership Appointment

* DANAHER CORP - BOARD OF DIRECTORS IS APPOINTING JOAKIM WEIDEMANIS TO POSITION OF EXECUTIVE VICE PRESIDENT OF DANAHER CORPORATION

BRIEF-Quidel Says Confident In Validity Of Supply Agreement With Beckman Coulter To Sell BNP Assay Assets

* QUIDEL CONFIDENT IN LEGAL STRENGTH AND VALIDITY OF SUPPLY AGREEMENT WITH BECKMAN COULTER TO SELL BNP ASSAY ASSETS

BRIEF- IDBS says has been acquired by Danaher Corp

* U.K's IDBS says has been acquired by the life sciences platform of Danaher Corp Source text - http://bit.ly/2yYOOLb Further company coverage:

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up